Despite being a polyclonal pool, up to 50% of the TdLN CD8+ PD-1+ repertoire overlap with the tumor suggesting that a large fraction of antigen experienced TdLN T cells are tumor specific even under untreated conditions (Figure 3B). This evidence concerns the gene CD8A and neoplasm.